Abstract
This article summarizes the most important recent articles on colonoscopy as a screening tool for colorectal cancer, presenting screening outcomes and quality issues. We also refer to the first published results of CT colonography screening in the United States and cost-effectiveness analyses of this method. Also discussed are recent progress in fecal DNA testing and studies of the impact of screening on mortality and lifestyle.
Similar content being viewed by others
References and Recommended Reading
Globocan 2002 Database. Lyon, France: International Agency for Research on Cancer, 2005. Available at http://www.dep.iarc.fr. Accessed August 31, 2007.
Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43–66.
Winawer SJ, Zauber AG, Ho MN, et al.: Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993, 329:1977–1981.
Mandel JS, Bond JH, Church TR, et al.: Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993, 328:1365–1371. [Published erratum appears in N Engl J Med 1993, 329:672.]
Gupta AK, Melton LJ III, Petersen GM, et al.: Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study. Clin Gastroenterol Hepatol 2005, 3:150–158.
Regula J, Zagorowicz E, Butruk E: Implementation of a national colorectal cancer screening program. Curr Colorectal Cancer Rep 2006, 2:25–29.
Regula J, Rupinski M, Kraszewska E, et al.: Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006, 355:1863–1872.
Barclay RL, Vicari JJ, Doughty AS, et al.: Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006, 355:2 588–2 589.
Farrar WD, Sawhney MS, Nelson DB, et al.: Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol 2006, 4:1259–1264.
Pickhardt PJ, Taylor AJ, Kim DH, et al.: Screening for colorectal neoplasia with CT colonography: initial experience from the 1st year of coverage by third-party payers. Radiology 2006, 241:417–425.
Vijan S, Hwang I, Inadomi J, et al.: The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterol 2007, 102:380–390.
Pickhardt PJ, Hassan C, Laghi A, et al.: Cost-effectiveness of colorectal cancer screening with computed tomography colonography: the impact of not reporting diminutive lesions. Cancer 2007, 109:2213–2221.
Imperiale TF, Ransohoff DF, Itzkowitz SH, et al.; Colorectal Cancer Study Group: Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004, 351:2704–2714.
Itzkowitz SH, Jandorf L, Brand R, et al.: Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007, 5:111–117.
Moayyedi P, Achkar E: Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data. Am J Gastroenterol 2006, 101:380–384.
Larsen IK, Grotmol T, Almendingen K, Hoff G: Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial. Clin Gastroenterol Hepatol 2007, 5:477–483.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zagorowicz, E., Regula, J. Colorectal cancer screening: Selected issues. Curr colorectal cancer rep 4, 14–18 (2008). https://doi.org/10.1007/s11888-008-0004-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11888-008-0004-3